Premier, Inc. stockholders overwhelmingly approved the acquisition by Patient Square Capital.
The transaction is expected to close on November 25, 2025.
Shareholders voted in favor of the acquisition, with approximately 99% of shares voted in favor.
Transaction Approval
99% of shareholders voted in favor of the acquisition, representing 79% of total outstanding shares.
Acquisition Details
Each Premier stockholder will receive $28.25 in cash per share, a 23.8% premium to the 60-day average price.
Expected Closure
The transaction is anticipated to close on or about November 25, 2025, contingent on meeting closing conditions.
- Premier, Inc. is set to be acquired by Patient Square Capital, a move that has received overwhelming approval from shareholders.
- The acquisition is expected to bring strategic benefits to both companies and align with their long-term objectives.
The acquisition approval marks a significant milestone for Premier, Inc. and solidifies its path towards a successful transition under Patient Square Capital.